Vaccine Code Set Update Publication Date: January 26, 2023
The individual filenames included in this distribution contain the publication date (20230126)
Release Notes: This release includes updates for vaccine codes and maps. It does not include VIS related code updates or any COVID-19 related updates.
Release notes are designed as a guide to highlight changes that have been made to the vaccine codes since the last publication. They should not be used as the primary source of code information. The vaccine code files themselves should be utilized.
General Note Regarding This Release: Codes with "Last Update" dates from 12/20/2022 to 1/19/2023, reflect the changes and additions in this release. This release includes the following code set updates:
Vaccine Code Set Update SummaryVaccine Code Set Updates Not Related to COVID-19 1. CVX Code Updates: - Changes to three CVX code descriptions to standardize dose volume formatting.
2. NDC Code Updates: - NDCs Added – New ebola vaccine NDCs for ERVEBO product
3. NDCs Codes Retired: - 16 Unit of Sale and Unit of Use NDC pairs retired
4. Other – Final Notes |
---|
Vaccine Code Set Update Details
The core CDC IIS vaccine data code sets have been updated to reflect the changes in this release. These can be found at IIS Data Code Sets | CDC Vaccine Code Updates Not Related to COVID-19 1. CVX Code Updates:
- Three CVX codes; 197, 203, and 205 had their descriptions updated to standardize and improve readability of the representation of the dose volume by adding a leading 0 before the decimal where appropriate (e.g. 0.5 mL vs .5 mL).
- CVX 204 had the note field updated, removing notation that NDCs were not yet available.
2. NDC Code Updates:
- New ebola ERVEBO vaccine NDCs have now been added and mapped to existing ebola CVX code 204 and MVX code MSD. All other associations to CVX 204 (CPT, VIS, Product Tradename) had been previously established. New NDCs for ERVEBO are shown below:
Sale Proprietary Name | Sale Labeler | Unit of Sale NDC11 | Unit of Use NDC11 | CVX Code | CVX Description | MVX Code |
---|
ERVEBO | Merck Sharp & Dohme LLC | 00006-4293-02 | 00006-4293-0 | 204 | Ebola Zaire vaccine, live, recombinant, 1mL dose | MSD |
---|
3. NDC Codes Retired
The following NDC Unit of Sale and Unit of Use pairs have been retired from the FDA files and end dates set on the codes in this code set release. Sale Proprietary Name | Sale Labeler | Sale NDC11 | Use NDC11 |
---|
DENGVAXIA | Sanofi Pasteur Inc. | 49281-0605-01 | 49281-0606-58 |
---|
FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | 49281-0322-50 | 49281-0322-88 |
---|
FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE | Sanofi Pasteur Inc. | 49281-0339-15 | 49281-0339-78 |
---|
HEPLISAV-B | Dynavax Technologies Corporation | 43528-0003-05 | 43528-0003-01 |
---|
IMOVAX RABIES | Sanofi Pasteur Inc. | 49281-0252-51 | 49281-0246-58 |
---|
INFANRIX | A-S Medication Solutions | 50090-2883-00 | 50090-2883-09 |
---|
Menactra | Sanofi Pasteur Inc. | 49281-0589-05 | 49281-0589-58 |
---|
RabAvert | Bavarian Nordic A/S | 50632-0010-01 | 50632-0013-01 |
---|
Shingrix | A-S Medication Solutions | 50090-5147-00 | 58160-0828-01 |
---|
STAMARIL | Sanofi Pasteur Inc. | 49281-0913-01 | 49281-0913-01 |
---|
TENIVAC | Sanofi Pasteur Inc. | 49281-0215-10 | 49281-0215-58 |
---|
TENIVAC | Sanofi Pasteur Inc. | 49281-0215-15 | 49281-0215-88 |
---|
Typhim Vi | Sanofi Pasteur Inc. | 49281-0790-20 | 49281-0790-38 |
---|
Typhim Vi | Sanofi Pasteur Inc. | 49281-0790-51 | 49281-0790-88 |
---|
YF-VAX | Sanofi Pasteur Inc. | 49281-0915-01 | 49281-0915-58 |
---|
YF-VAX | Sanofi Pasteur Inc. | 49281-0915-05 | 49281-0915-68 |
---|
4. Other - Final Notes
- In addition to the NDC updates listed above, FDA files received and processed by the CDC included minor changes to two UoS and UoU pairs where the FDA modified the ingredient descriptions and 2 other pairs where the CDC set end dates in 2022, and the FDA retired the NDCs from their files now. These changes did not impact CDC codes or information published in the CDC files. However, the updates did change the date of last update on the affected records.
- Eight CVX codes had internal updates that are not visible on the files published by the CDC but did change the date of last update on those records.
|
---|